BlackRock Ebitda from 2010 to 2024

BSTZ Stock  USD 21.32  0.21  0.98%   
BlackRock Science EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, BlackRock Science EBITDA regression line of annual values had significance of  0.97 and arithmetic mean of  140,307,011. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
280.4 M
Current Value
294.4 M
Quarterly Volatility
537.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BlackRock Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BlackRock Science's main balance sheet or income statement drivers, such as Interest Income of 0.0, Interest Expense of 25.5 K or Selling General Administrative of 1.4 M, as well as many indicators such as Price To Sales Ratio of 3.69, Dividend Yield of 0.0633 or PTB Ratio of 1.09. BlackRock financial statements analysis is a perfect complement when working with BlackRock Science Valuation or Volatility modules.
  
Check out the analysis of BlackRock Science Correlation against competitors.

Latest BlackRock Science's Ebitda Growth Pattern

Below is the plot of the Ebitda of BlackRock Science and over the last few years. It is BlackRock Science's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BlackRock Science's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Very volatile
   Ebitda   
       Timeline  

BlackRock Ebitda Regression Statistics

Arithmetic Mean140,307,011
Coefficient Of Variation383.35
Mean Deviation232,952,379
Median113,229,299
Standard Deviation537,871,517
Sample Variance289305.8T
Range2.8B
R-Value(0.01)
Mean Square Error311532.2T
R-Squared0.000089
Significance0.97
Slope(1,137,428)
Total Sum of Squares4050280.8T

BlackRock Ebitda History

2024294.4 M
2023280.4 M
2022-1.3 B
2021248.5 M
20201.5 B

About BlackRock Science Financial Statements

BlackRock Science investors use historical fundamental indicators, such as BlackRock Science's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BlackRock Science. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA280.4 M294.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BlackRock Stock Analysis

When running BlackRock Science's price analysis, check to measure BlackRock Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Science is operating at the current time. Most of BlackRock Science's value examination focuses on studying past and present price action to predict the probability of BlackRock Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Science's price. Additionally, you may evaluate how the addition of BlackRock Science to your portfolios can decrease your overall portfolio volatility.